Cited by 5Attention Deficit Hyperactivity DisorderPharmaceutical studies and practicesClinical practice guidelines implementation

Adherence to clinical guidelines for dose finding and monitoring methylphenidate use: a medical record audit in child and adolescent mental health care and pediatric settings

Open access
Rosenau, Paul T., Dietrich, Andrea, Matthijssen, Anne-Flore M., Kleine-Deters, Renee, van de Loo-Neus, Gigi H.H., Buitelaar, Jan K., van den Hoofdakker, Barbara J., Hoekstra, Pieter J.·2023·Journal of Child and Adolescent Psychopharmacology

Abstract

Background: Guideline adherence is important to ensure optimal and safe use of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder (ADHD). We investigated adherence to Dutch guidelines regarding dosing and monitoring of methylphenidate in child and adolescent mental health care and pediatric treatment settings. Methods: Five hundred six medical records of children and adolescents were investigated in 2015 and 2016. We assessed adherence to the following guideline recommendations: (1) at least four visits during the dose-finding phase; (2) monitoring thereafter at least every 6 months; (3) measuring height and weight at least annually; and (4) the use of validated questionnaires to assess treatment response. Pearson's chi-squared test statistics were used to examine differences between settings. Results: Only a small portion of patients had at least four visits during the dose-finding phase (5.1% in the first 4 weeks to 12.4% in the first 6 weeks). Also, less than half of the patients (48.4%) were seen at least every 6 months. Height was recorded at least annually in 42.0% of patients, weight in 44.9%, and both recorded in a growth chart in 19.5%. Questionnaires to assess treatment response were only used in 2.3% of all visits. When comparing both settings, more patients in the pediatric settings were seen every 6 months, although height and weight were recorded more often in the mental health care setting. Conclusion: Overall, guideline adherence was low. Training of clinicians and adding guideline recommendations to electronic medical records templates may improve adherence. Additionally, we should aim to close the gap between guidelines and clinical practice by looking critically at the feasibility of guidelines.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/cap.2022.0095

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 19

  1. Braithwaite J, Hibbert PD, Jaffe A, et al. Quality of health care for children in Australia, 2012-2013. JAMA 2018;319(11):1113-1124.
  2. Bussing R, Fernandez M, Harwood M, et al. Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symp- toms: Psychometric properties and normative ratings from a school district sample. Assessment 2008;15(3):317-328.
  3. Cabana MD, Rand CS, Powe NR, et al. Why don' t physicians follow a framework for improvement. JAMA 1999;282(15):1458-1465.
  4. Canadian ADHD Resource Alliance. Canadian ADHD Practice Guidelines, Fourth Edition. Canadian ADHD Resource Alliance (CADDRA): Toronto, Canada; 2018.
  5. Carroll AE, Bauer NS, Dugan TM, et al. Use of a computerized decision aid for ADHD diagnosis: A randomized controlled trial. Pediatrics 2013;132(3):e623-9.
  6. Carucci S, Balia C, Gagliano A, et al. Long Term Methylphenidate Exposure and Growth in Children and adolescents with ADHD. A Systematic Review and Meta-Analysis. In: Neuroscience and Biobehavioral Reviews (Vol. 120). Elsevier Ltd, 2021; pp. 509-525.
  7. Epstein JN, Langberg JM, Lichtenstein PK, et al. Community-wide intervention to improve the attention-deficit/hyperactivity disorder assessment and treatment practices of community physicians. Pe- diatrics 2008;122(1):19-27.
  8. Epstein JN, Langberg JM, Lichtenstein PK, et al. Use of an internet portal to improve community-based pediatric ADHD care: A cluster randomized trial. Pediatrics 2011;128(5):e1201-8.
  9. Group TMC. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56(12):1073-1086.
  10. Harpaz-Rotem I, Rosenheck RA. Prescribing practices of psychiatrists and primary care physicians caring for children with mental illness. Child Care Health Dev 2006;32(2):225-238.
  11. Hodgkins P, Sasane ´R, Meijer WM. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: Incidence, prevalence, and treatment patterns in The Netherlands. Clin Ther 2011;33(2):188-203.
  12. Levelink B, Walraven L, Dompeling E, et al. Guideline use among different healthcare professionals in diagnosing attention deficit hyperactivity disorder in Dutch children; who cares? BMC Psychol 2019;7(1):1-8.
  13. Lugtenberg M, Van Beurden KM, Brouwers EPM, et al. Occupational physicians' perceived barriers and suggested solutions to improve adherence to a guideline on mental health problems: Analysis of a peer group training. BMC Health Serv Res 2016;16(1):1-11.
  14. Matthijssen AFM, Dietrich A, Kleine Deters R, et al. Clinicians' adherence to guidelines when initiating methylphenidate treatment. J Child Adolesc Psychopharmacol 2022;32(9):488-495.
  15. National Institute for Health and Care Excellence. Attention Deficit Hyperactivity Disorder. The NICE Guideline on Diagnosis and Management of ADHD in Children, Young People and Adults. In: National Clinical Practice Guideline Number 72 (Vol. 2009). British Psychological Society (UK): Leicester, United Kingdom; 2009. https://www.ncbi.nlm.nih.gov/books/NBK53652/ [Last ac- cessed March: 25, 2019].
  16. Thomas CP, Conrad P, Casler R, et al. Trends in the use of psycho- tropic medications among adolescents, 1994 to 2001. Psychiatr Serv 2006;57(1):63-69.
  17. van Widenfelt BM, Goedhart AW, Treffers PDA, et al. Dutch version of the strengths and difficulties questionnaire (SDQ). Eur Child Adolesc Psychiatry 2003;12(6):281-289.
  18. Vrba K, Vogel W, de Vries PJ. Management of ADHD in children and adolescents: Clinical audit in a South African setting. J Child Adolesc Ment Health 2016;28(1):1-19.
  19. Zhang S, Faries DE, Vowles M, et al. ADHD Rating Scale IV: Psy- chometric properties from a multinational study as a clinician- administered instrument. Int J Methods Psychiatr Res 2005;14(4): 186-201.

Cited by

Sorted by citations

Authors
Rosenau, P. T., Dietrich, A., Matthijssen, A.-F. M., Kleine-Deters, R., van de Loo-Neus, G. H. H., Buitelaar, J. K., van den Hoofdakker, B. J., & Hoekstra, P. J.
Affiliations
  • University Medical Center Groningen (NL)
  • Department of Child and Adolescent Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Karakter Child and Adolescent Psychiatry Center Nijmegen, Nijmegen, The Netherlands.
  • Radboud University Nijmegen (NL)
Corresponding author
Rosenau, Paul T.
Venue
Journal of Child and Adolescent Psychopharmacology
Published
2023-06
Volume
33
Issue
5
Pages
183-189
ISSN
  • 1044-5463 (ISSN-L)
  • 1557-8992
OpenAlex
W4381331383
Cited by
5
References
0
Citations by year
2025: 3 · 2024: 1 · 2023: 1
FWCI
1.02
Type
journal article
Language
en
Open access
Locations
  • Journal of Child and Adolescent Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
Funders
ZonMw (836011014)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords
methylphenidate, attention deficit hyperactivity disorder, guideline adherence, dose-finding, therapeutic drug monitoring, child and adolescent mental health services, growth monitoring, height and weight measurement, treatment response assessment, electronic health records
MeSH terms
Adolescent, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Humans, Mental Health, Methylphenidate, Surveys and Questionnaires, Electronic Health Records

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review